Distributors / Reps

Find out how IMDA can help you achieve excellence in specialty sales and marketing.



Meet an IMDA Member - OE Meyer Co

OE Meyer

Kevin Turner
Vice president sales and marketing
(419) 625-3054

OE Meyer is an anesthesia/respiratory specialty dealer focused on helping our customers navigate the complex healthcare landscape and address product fulfillment needs and services. Doing what's right has resulted in long-standing customer relationships and satisfaction.

In today's environment of healthcare supplier consolidation, it can be frustrating when suppliers seem more focused on internal interests than on you. OE Meyer Co. is a diverse team of problem solvers that deliver continuity of service, expertise, and consistent representation. We'll be there when you need convenient, cost-effective, and comprehensive solutions. 

Here's what you can expect from OE Meyer Co.:

  • Professionally trained employee owners.
  • Same day shipping for orders placed by 3:00 p.m. EST.
  • 99 percent of established product orders ship same day.
  • Customer-based shipping preferences. Dedicated OE Meyer Co. drivers can deliver to many customer locations, or within 1-2 days via common carrier.
  • Product samples: Just ask…we can help.
  • No-hassle return policy.


IMDA eNews       10/17/2017

Cybersecurity bill introduced. A bill to create a public-private partnership to lay out a cybersecurity framework was introduced by U.S. Reps. Dave Trott and Susan Brooks. “Bad actors are not only looking to access sensitive information, but they are also trying to manipulate device functionality,” said Rep. Brooks, referring to The Internet of Medical Things Resilience Partnership Act. “This can lead to life-threatening cyber-attacks on devices ranging from monitors and infusion pumps, to ventilators and radiological technologies. As the number of connected medical devices continue to grow, so does the urgency to establish guidelines for how to prevent these kinds of dangerous attacks.”



Medical technology: Looking good. Medical technology innovation continues to drive growth, according to EY’s Pulse of the Industry 2017 report, released at the annual conference of AdvaMed. In 2016, the U.S. Food & Drug Administration approved 39 new class III medical devices via its pre-market approval (PMA) pathway, reports EY. As of July 31, 2017, there were 26 PMA approvals, putting the industry on track to nearly rival the approval numbers last achieved in 2004. The uptick in approvals that began in 2015 suggests that medtechs are beginning to adapt to higher regulatory and reimbursement thresholds and are investing proactively in safety and efficacy studies to better demonstrate the utility of their devices.



Public/private partnership for medical devices. Mayo Clinic and Boston Scientific have jointly filed a patent application for a catheter designed to allow heart surgeons to become more efficient when performing aortic valve replacements, reports Twin Cities Business. The development is part of an intellectual property collaboration announced between the two last year. Called a self-centering guide catheter, the device is meant to help surgeons efficiently thread a guidewire through a narrowed aortic valve opening in a heart affected by calcification. It is being developed by a team led by Mayo cardiologist Dr. Gurpreet Sandhu and Boston Scientific research fellow Roger McGowan.



Bundling programs outlook uncertain. Hospitals generally support the proposed cancellation of the cardiac and Surgical Hip and Femur Fracture Treatment bundling program and Comprehensive Care for Joint Replacement bundling program, and partial conversion of the CJR program to a voluntary model, American Hospital Association Executive Vice President Tom Nickels told the Centers for Medicare & Medicaid Services in comments submitted to CMS Oct. 10. However, some hospitals have concerns, leading AHA to urge CMS to “expeditiously pursue the creation of new, voluntary advanced [alternative payment models] that would allow hospitals to not only capitalize on the work many of them already have done to prepare for such models, but also partner with clinicians to provide better, more efficient care.”